Trastuzumab deruxtecan (DS-8201a) in patients with advanced HER2-positive breast cancer previously treated with trastuzumab emtansine: a dose-expansion, phase 1 study-Reference-Cited by-同舟云学术

Trastuzumab deruxtecan (DS-8201a) in patients with advanced HER2-positive breast cancer previously treated with trastuzumab emtansine: a dose-expansion, phase 1 study

Published:2019-06 Issue:6 Volume:20 Page:816-826
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Tamura Kenji,Tsurutani Junji,Takahashi Shunji,Iwata Hiroji,Krop Ian E,Redfern Charles,Sagara Yasuaki,Doi Toshihiko,Park Haeseong,Murthy Rashmi K,Redman Rebecca A,Jikoh Takahiro,Lee Caleb,Sugihara Masahiro,Shahidi Javad,Yver Antoine,Modi Shanu

Publisher

Elsevier BV

Subject

Oncology

Reference36 articles.

1. US incidence of breast cancer subtypes defined by joint hormone receptor and HER2 status;Howlader;J Natl Cancer Inst,2014

2. Annual report to the nation on the status of cancer, 1975–2011, featuring incidence of breast cancer subtypes by race/ethnicity, poverty, and state;Kohler;J Natl Cancer Inst,2015

3. Breast cancer subtypes based on ER/PR and HER2 expression: comparison of clinicopathologic features and survival;Onitilo;Clin Med Res,2009

4. 3rd ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 3);Cardoso;Ann Oncol,2017

5. Systemic therapy for patients with advanced human epidermal growth factor receptor 2-positive breast cancer: American Society of Clinical Oncology clinical practice guideline;Giordano;J Clin Oncol,2014

Cited by 279 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel antibody-drug conjugates based on DXd-ADC technology;Bioorganic Chemistry;2024-10

2. Prognostic significance of low HER2 expression in gastric cancer: a retrospective, single-center analysis;BMC Cancer;2024-09-02

3. Quantitative Measurement of HER2 Expression in Non–Small Cell Lung Cancer With a High-Sensitivity Assay;Modern Pathology;2024-09

4. Expanding treatment options for patients with HER2+ metastatic breast cancer with margetuximab plus chemotherapy: a case report series;Frontiers in Oncology;2024-08-16

5. The radiologist’s role in detecting systemic anticancer therapy-related interstitial lung disease: an educational review;Insights into Imaging;2024-08-01